A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
|2||Not yet recruiting||
Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia
Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML
† Study has passed its completion date and status has not been verified in more than two years.